Therapeutic drug monitoring of voriconazole and posaconazole for invasive aspergillosis
Published 2013 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Therapeutic drug monitoring of voriconazole and posaconazole for invasive aspergillosis
Authors
Keywords
-
Journal
Expert Review of Anti-Infective Therapy
Volume 11, Issue 9, Pages 931-941
Publisher
Informa UK Limited
Online
2013-09-23
DOI
10.1586/14787210.2013.826989
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Pharmacokinetic Profile of Voriconazole in a Critically Ill Patient on Therapeutic Plasma Exchange
- (2013) Isabel Spriet et al. THERAPEUTIC DRUG MONITORING
- Plasma Concentrations of Posaconazole Administered via Nasogastric Tube in Patients in a Surgical Intensive Care Unit
- (2012) Dominic Störzinger et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Multicenter Study of Posaconazole Therapeutic Drug Monitoring: Exposure-Response Relationship and Factors Affecting Concentration
- (2012) Michael J. Dolton et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Prospective, Observational Study of Voriconazole Therapeutic Drug Monitoring among Lung Transplant Recipients Receiving Prophylaxis: Factors Impacting Levels of and Associations between Serum Troughs, Efficacy, and Toxicity
- (2012) Dimitra Mitsani et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Multicenter Study of Voriconazole Pharmacokinetics and Therapeutic Drug Monitoring
- (2012) Michael J. Dolton et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Integrated Population Pharmacokinetic Analysis of Voriconazole in Children, Adolescents, and Adults
- (2012) Lena E. Friberg et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- The Effect of Therapeutic Drug Monitoring on Safety and Efficacy of Voriconazole in Invasive Fungal Infections: A Randomized Controlled Trial
- (2012) Wan Beom Park et al. CLINICAL INFECTIOUS DISEASES
- Factors influencing the pharmacokinetics of prophylactic posaconazole oral suspension in patients with acute myeloid leukemia or myelodysplastic syndrome
- (2012) J. J. Vehreschild et al. EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY
- A new solid oral tablet formulation of posaconazole: a randomized clinical trial to investigate rising single- and multiple-dose pharmacokinetics and safety in healthy volunteers
- (2012) G. Krishna et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- Efficacy and pharmacodynamics of voriconazole combined with anidulafungin in azole-resistant invasive aspergillosis
- (2012) S. Seyedmousavi et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- Posaconazole after previous antifungal therapy with voriconazole for therapy of invasive aspergillus disease, a retrospective analysis
- (2012) Werner J. Heinz et al. MYCOSES
- Observational Study of the Clinical Efficacy of Voriconazole and Its Relationship to Plasma Concentrations in Patients
- (2011) Peter F. Troke et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Lack of Evidence for Exposure–Response Relationship in the Use of Posaconazole as Prophylaxis Against Invasive Fungal Infections
- (2011) O A Cornely et al. CLINICAL PHARMACOLOGY & THERAPEUTICS
- Current Concepts in Antifungal Pharmacology
- (2011) Russell E. Lewis MAYO CLINIC PROCEEDINGS
- A Twice Daily Posaconazole Dosing Algorithm for Children With Chronic Granulomatous Disease
- (2011) Marieke E. B. Welzen et al. PEDIATRIC INFECTIOUS DISEASE JOURNAL
- Posaconazole: The Case for Therapeutic Drug Monitoring
- (2011) Susan J Howard et al. THERAPEUTIC DRUG MONITORING
- Multiplex Ultra-Performance Liquid Chromatography-Tandem Mass Spectrometry Method for Simultaneous Quantification in Human Plasma of Fluconazole, Itraconazole, Hydroxyitraconazole, Posaconazole, Voriconazole, Voriconazole-N-Oxide, Anidulafungin, and Caspofungin
- (2010) L. A. Decosterd et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Impact of cyp51A Mutations on the Pharmacokinetic and Pharmacodynamic Properties of Voriconazole in a Murine Model of Disseminated Aspergillosis
- (2010) E. Mavridou et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Azole Binding Properties of Candida albicans Sterol 14- Demethylase (CaCYP51)
- (2010) A. G. S. Warrilow et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Exposure–Response of Posaconazole Used for Prophylaxis Against Invasive Fungal Infections: Evaluating the Need to Adjust Doses Based on Drug Concentrations in Plasma
- (2010) S H Jang et al. CLINICAL PHARMACOLOGY & THERAPEUTICS
- Efficacy of Posaconazole against Three Clinical Aspergillus fumigatus Isolates with Mutations in the cyp51A Gene
- (2009) E. Mavridou et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Clinical Relevance of the Pharmacokinetic Interactions of Azole Antifungal Drugs with Other Coadministered Agents
- (2009) Roger J. M. Brüggemann et al. CLINICAL INFECTIOUS DISEASES
- Voriconazole Pharmacokinetics and Pharmacodynamics in Children
- (2009) Michael Neely et al. CLINICAL INFECTIOUS DISEASES
- Voriconazole concentrations and outcome of invasive fungal infections
- (2009) S. Miyakis et al. CLINICAL MICROBIOLOGY AND INFECTION
- Monitoring trough concentration of voriconazole is important to ensure successful antifungal therapy and to avoid hepatic damage in patients with hematological disorders
- (2009) Koki Ueda et al. INTERNATIONAL JOURNAL OF HEMATOLOGY
- Pharmacokinetics and safety of 14 days intravenous voriconazole in allogeneic haematopoietic stem cell transplant recipients
- (2009) R. J. M. Bruggemann et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- Method for therapeutic drug monitoring of azole antifungal drugs in human serum using LC/MS/MS
- (2009) J.W.C. Alffenaar et al. JOURNAL OF CHROMATOGRAPHY B-ANALYTICAL TECHNOLOGIES IN THE BIOMEDICAL AND LIFE SCIENCES
- Tolerability and safety profile of posaconazole: evaluation of 18 controlled studies in healthy volunteers
- (2009) A. Moton et al. JOURNAL OF CLINICAL PHARMACY AND THERAPEUTICS
- International Interlaboratory Proficiency Testing Program for Measurement of Azole Antifungal Plasma Concentrations
- (2008) R. J. M. Bruggemann et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Population Pharmacokinetic Analysis of Voriconazole Plasma Concentration Data from Pediatric Studies
- (2008) M. O. Karlsson et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Treatment of Aspergillosis: Clinical Practice Guidelines of the Infectious Diseases Society of America
- (2008) Thomas J. Walsh et al. CLINICAL INFECTIOUS DISEASES
- Therapeutic drug monitoring for triazoles
- (2008) William W Hope et al. CURRENT OPINION IN INFECTIOUS DISEASES
- Posaconazole concentrations in the central nervous system
- (2008) M. J. G. T. Ruping et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- Renal impairment and Amphotericin B formulations in patients with invasive fungal infections
- (2008) Faouzi Saliba et al. MEDICAL MYCOLOGY
- Current Options in Antifungal Pharmacotherapy
- (2008) John Mohr et al. PHARMACOTHERAPY
- Voriconazole Therapeutic Drug Monitoring in Patients with Invasive Mycoses Improves Efficacy and Safety Outcomes
- (2007) A. Pascual et al. CLINICAL INFECTIOUS DISEASES
Become a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get StartedAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started